FindTrial
Sign In

National Prospective Hospital Cohort Study of Osteoporosis combined disease with 'zheng'

A prospective cohort study of community-based tertiary prevention of osteoporotic fractures and the effect of kidney invigorating therapy in Guangdong

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900028167
Enrollment
Unknown
Registered
2019-12-14
Start date
2019-12-12
Completion date
Unknown
Last updated
2019-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoporosis

Interventions

None listed

Sponsors

The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged >=40 years; 2. Gender: male or female; 3. Voluntarily participate in this research and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Suffering from diseases that affect bone metabolism, such as malignant tumors, diabetes, thyroid disease, parathyroid disease, adrenal disease, chronic liver and kidney disease; 2. Take antiepileptic drugs, letrozole, immunosuppressants and other drugs that affect bone metabolism. 3. Have undergone a total hysterectomy; 4. Have received regular anti-osteoporosis treatment.

Design outcomes

Primary

MeasureTime frame
BMD;—

Countries

China

Contacts

Public ContactXiaobing Jiang

The First Affiliated Hospital of Guangzhou University of Chinese Medicine

1522007025@qq.com+86 13632494486

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026